National Health (Listed drugs on F1 or F2) Amendment Determination 2011 (No. 3) (No. PB 20 of 2011) (Cth)
National Health (Listed drugs on F1 or F2) Amendment Determination 2011 (No.3)1
Instrument number PB 20 of 2011
National Health Act 1953
I, ADRIANA PLATONA, Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this determination under subsection 85AB(1) of the National Health Act 1953.
Dated 28 February 2011
ADRIANA PLATONA
Assistant Secretary
Pharmaceutical Evaluation Branch
Pharmaceutical Benefits Division
Department of Health and Ageing
Part 1 Preliminary
Name of Determination
(1) This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2011 (No.3).
(2) This Determination may also be cited as PB 20 of 2011.
Commencement
This Determination commences on 1 March 2011.
Amendment of National Health (Listed drugs on F1 or F2) Determination 2010
Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).
Schedule 1 Amendments
(Section 3)
[1] Schedule 1, after item dealing with Amino acid formula with vitamins and minerals without valine, leucine and isoleucine with fat, carbohydrate and trace elements and supplemented with docosahexanoic
Omit
Amino acid formula with vitamins and minerals without lysine and low in tryptophane
Insert
Amino acid formula with vitamins and minerals without lysine and low in tryptophan
[2] Schedule 1, after item dealing with Cinacalcet
Insert
Citrulline with carbohydrate
[3] Schedule 1, after item dealing with Disopyramide
Omit
Docetaxel
[4] Schedule 2, after item dealing with Calcitriol
Omit
Calrithromycin
[5] Schedule 2, after item dealing with Diphenoxylate with atropine
Insert
Docetaxel
Note
1. All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. See
0
0
0